How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment

Risk for Hospital Contact With Infection in Patients With Splenectomy

(2013) Reimar W. Thomsen   ANNALS OF INTERNAL MEDICINE

Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program

(2011) M. Khellaf et al.   BLOOD

Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment

(2011) O. E. Yri et al.   BLOOD

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

(2011) C. Neunert et al.   BLOOD

Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients

(2011) Delphine Gobert et al.   BRITISH JOURNAL OF HAEMATOLOGY

Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents

(2011) Waleed Ghanima et al.   BRITISH JOURNAL OF HAEMATOLOGY

Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities

(2011) Leonardo Boiocchi et al.   MODERN PATHOLOGY

Evidence-Based Mini-Review: Is Indium-Labeled Autologous Platelet Scanning Predictive of Response to Splenectomy in Patients With Chronic Immune Thrombocytopenia?

(2011) A. Cuker et al.   Hematology-American Society of Hematology Education Program

Predictors for splenectomy among patients with primary chronic immune thrombocytopenia: a population-based cohort study from Denmark

(2010) Annette Østergaard Jensen et al.   ANNALS OF HEMATOLOGY

Costs of managing severe immune thrombocytopenia in adults: a retrospective analysis

(2010) Mehdi Khellaf et al.   ANNALS OF HEMATOLOGY

Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debate

(2010) Roberto Stasi et al.   ANNALS OF HEMATOLOGY

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

(2010) F. Zaja et al.   BLOOD

Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents

(2010) W. Bao et al.   BLOOD

Pregnancy outcomes after maternal exposure to rituximab

(2010) E. F. Chakravarty et al.   BLOOD

Autologous 111In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry

(2010) Ameet Sarpatwari et al.   BRITISH JOURNAL OF HAEMATOLOGY

Low-dose rituximab in adult patients with primary immune thrombocytopenia

(2010) Francesco Zaja et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: a 10-year nationwide cohort study

(2010) R. W. THOMSEN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia

(2010) David J. Kuter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thrombopoietic Agents in Immune Thrombocytopenia

(2010) Waleed Ghanima et al.   SEMINARS IN HEMATOLOGY

Toxicities of the Thrombopoietic Growth Factors

(2010) Adam Cuker   SEMINARS IN HEMATOLOGY

Computed tomography to detect accessory spleens before laparoscopic splenectomy: is it necessary?

(2010) Conal Quah et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

Repeated courses of rituximab in chronic ITP: Three different regimens

(2009) Aisha Hasan et al.   AMERICAN JOURNAL OF HEMATOLOGY

Short-term and long-term failure of laparoscopic splenectomy in adult immune thrombocytopenic purpura patients: A systematic review

(2009) Joseph Mikhael et al.   AMERICAN JOURNAL OF HEMATOLOGY

Vascular complications after splenectomy for hematologic disorders

(2009) S. E. Crary et al.   BLOOD

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

The ITP syndrome: pathogenic and clinical diversity

(2009) D. B. Cines et al.   BLOOD

Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production

(2009) Diane Nugent et al.   BRITISH JOURNAL OF HAEMATOLOGY

Mortality risk in splenectomised patients: A Danish population-based cohort study

(2009) Mellissa Yong et al.   European Journal of Internal Medicine

Definition, diagnosis and treatment of immune thrombocytopenic purpura

(2009) J. N. George   HAEMATOLOGICA

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

(2009) James B Bussel et al.   LANCET

Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP

(2008) J. B. Bussel et al.   BLOOD

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

(2008) B. Godeau et al.   BLOOD

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

(2008) F. Rodeghiero et al.   BLOOD

Rituximab in the treatment of autoimmune haematological disorders

(2008) Bernadette Garvey   BRITISH JOURNAL OF HAEMATOLOGY

Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials

(2008) James N. George et al.   BRITISH JOURNAL OF HAEMATOLOGY

Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results

(2008) Marta Medeot et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

(2008) David J Kuter et al.   LANCET

Increased procoagulant cell-derived microparticles (C-MP) in splenectomized patients with ITP

(2008) V. Fontana et al.   THROMBOSIS RESEARCH

Is splenectomy still the gold standard for the treatment of chronic ITP?

(2007) Francesco Rodeghiero et al.   AMERICAN JOURNAL OF HEMATOLOGY

Splenectomy for immune thrombocytopenic purpura: Surgery for the 21st century

(2007) James P. Dolan et al.   AMERICAN JOURNAL OF HEMATOLOGY